Total Funding
25
2
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
138724
A healthcare organisation in the business of commercialising novel medicines, medical devices and molecular diagnostics in Oncology.
About the Company
At Sayre Therapeutics, They focus on bringing hitherto unavailable novel medicines, drug-delivery devices, companion diagnostics and diagnostic imaging agents to medical oncologists, surgical oncologists, radiation oncologists, interventional radiologists and rheumatologists.These include, but are not limited to, small molecules, recombinant
proteins,monoclonal antibodies (mAbs),drug-delivery devices and diagnostics in Oncology and Immunology.Our business model encompasses Global access / early access programs, Named Patient programs and securing product registrations for exclusive commercial distribution in South Asia.
